HALO Financials
Halozyme Therapeutics Inc - Financial statements & key metrics
Stock Price
$106.94
Market Cap
$7.10B
P/E Ratio
15.3
EPS
$4.74
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.02B
Gross Profit
-
Operating Income
-
Net Income
$444.09M
EPS (Diluted)
$3.43
Balance Sheet Highlights
Total Assets
$2.06B
Total Liabilities
$1.70B
Shareholders Equity
-
Cash & Equivalents
$115.85M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$479.06M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
61.5%
Net Margin
47.9%
ROE
124.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is HALO revenue?
HALO's most recent quarterly revenue was $1.02B. Annual revenue can be calculated by summing the four most recent quarters.
Is HALO profitable?
HALO reported a profit of $444.09M in the most recent quarter. The net profit margin is 47.9%.
What is HALO market cap?
HALO has a market capitalization of $7.10B, making it a mid-cap stock.
Does HALO have debt?
View HALO's balance sheet for debt information.
What is HALO cash flow?
Cash flow data is available in the full financial statements.